An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera)
- PMID: 25405876
- PMCID: PMC4270108
- DOI: 10.1089/acm.2014.0177
An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera)
Abstract
Objective: To assess existing reported human trials of Withania somnifera (WS; common name, ashwagandha) for the treatment of anxiety.
Design: Systematic review of the literature, with searches conducted in PubMed, SCOPUS, CINAHL, and Google Scholar by a medical librarian. Additionally, the reference lists of studies identified in these databases were searched by a research assistant, and queries were conducted in the AYUSH Research Portal. Search terms included "ashwagandha," "Withania somnifera," and terms related to anxiety and stress. Inclusion criteria were human randomized controlled trials with a treatment arm that included WS as a remedy for anxiety or stress. The study team members applied inclusion criteria while screening the records by abstract review.
Intervention: Treatment with any regimen of WS.
Outcome measures: Number and results of studies identified in the review.
Results: Sixty-two abstracts were screened; five human trials met inclusion criteria. Three studies compared several dosage levels of WS extract with placebos using versions of the Hamilton Anxiety Scale, with two demonstrating significant benefit of WS versus placebo, and the third demonstrating beneficial effects that approached but did not achieve significance (p=0.05). A fourth study compared naturopathic care with WS versus psychotherapy by using Beck Anxiety Inventory (BAI) scores as an outcome; BAI scores decreased by 56.5% in the WS group and decreased 30.5% for psychotherapy (p<0.0001). A fifth study measured changes in Perceived Stress Scale (PSS) scores in WS group versus placebo; there was a 44.0% reduction in PSS scores in the WS group and a 5.5% reduction in the placebo group (p<0.0001). All studies exhibited unclear or high risk of bias, and heterogenous design and reporting prevented the possibility of meta-analysis.
Conclusions: All five studies concluded that WS intervention resulted in greater score improvements (significantly in most cases) than placebo in outcomes on anxiety or stress scales. Current evidence should be received with caution because of an assortment of study methods and cases of potential bias.
Figures
Similar articles
-
Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974.PLoS One. 2009 Aug 31;4(8):e6628. doi: 10.1371/journal.pone.0006628. PLoS One. 2009. PMID: 19718255 Free PMC article. Clinical Trial.
-
An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.Medicine (Baltimore). 2019 Sep;98(37):e17186. doi: 10.1097/MD.0000000000017186. Medicine (Baltimore). 2019. PMID: 31517876 Free PMC article. Clinical Trial.
-
Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. doi: 10.2174/1871524911006030238. Cent Nerv Syst Agents Med Chem. 2010. PMID: 20528765 Review.
-
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.Altern Med Rev. 2000 Aug;5(4):334-46. Altern Med Rev. 2000. PMID: 10956379 Review.
-
Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.Phytomedicine. 2003 Nov;10(8):631-9. doi: 10.1078/0944-7113-00369. Phytomedicine. 2003. PMID: 14692723 Clinical Trial.
Cited by 13 articles
-
Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis.Nutrients. 2020 Apr 17;12(4):1119. doi: 10.3390/nu12041119. Nutrients. 2020. PMID: 32316411 Free PMC article.
-
Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled, Two-Armed Cross-Over Study.Pharmaceuticals (Basel). 2020 Mar 14;13(3):45. doi: 10.3390/ph13030045. Pharmaceuticals (Basel). 2020. PMID: 32183355 Free PMC article.
-
Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology.Int J Mol Sci. 2019 Oct 25;20(21):5310. doi: 10.3390/ijms20215310. Int J Mol Sci. 2019. PMID: 31731424 Free PMC article. Review.
-
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males.Am J Mens Health. 2019 Mar-Apr;13(2):1557988319835985. doi: 10.1177/1557988319835985. Am J Mens Health. 2019. PMID: 30854916 Free PMC article. Clinical Trial.
-
Relationships among classifications of ayurvedic medicine diagnostics for imbalances and western measures of psychological states: An exploratory study.J Ayurveda Integr Med. 2019 Jul-Sep;10(3):198-202. doi: 10.1016/j.jaim.2018.02.001. Epub 2018 Oct 29. J Ayurveda Integr Med. 2019. PMID: 30385015 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Research Materials
-
Miscellaneous